Medtronic (MDT) Non-Current Deferred Tax Liability (2014 - 2026)

Medtronic has disclosed Non-Current Deferred Tax Liability across 13 years of filings, most recently posting $365.0 million for Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $365.0 million, down 19.25% year-over-year; the trailing twelve-month figure through Jan 2026 was $365.0 million (down 19.25% YoY), and the FY2025 annual result was $403.0 million, down 21.75% from the prior year.
• Non-Current Deferred Tax Liability came in at $365.0 million for Q1 2026 at Medtronic, down from $386.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.1 billion in Q2 2023 to a low of $365.0 million in Q1 2026.
• The 5-year median for Non-Current Deferred Tax Liability is $615.0 million (2024), against an average of $765.8 million.
• Across the five-year window, Non-Current Deferred Tax Liability advanced 5.76% in 2023 and plunged 75.19% in 2024, its largest moves.
• Medtronic's Non-Current Deferred Tax Liability stood at $871.0 million in 2022, then decreased by 21.24% to $686.0 million in 2023, then plunged by 31.05% to $473.0 million in 2024, then retreated by 18.39% to $386.0 million in 2025, then dropped by 5.44% to $365.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $365.0 million (Q1 2026), $386.0 million (Q4 2025), and $416.0 million (Q3 2025), per Business Quant data.